The influence of safety warnings on the prescribing of JAK inhibitors
Mark Russell, Zijing Yang, Ben Walter, Edward Alveyn, Katie Bechman, Aitana Miracle, Deepak Nagra, Maryam Adas, Sam Norton, Andrew P. Cope, Sinéad Langan, James Galloway
Topics & Concepts
TofacitinibMedicinePsoriatic arthritisJanus kinaseRheumatoid arthritisJanus kinase inhibitorDermatologyArthritisRuxolitinibInternal medicineReceptorBone marrowMyelofibrosisRheumatoid Arthritis Research and TherapiesCytokine Signaling Pathways and InteractionsSpondyloarthritis Studies and Treatments